IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-37874-2.html
   My bibliography  Save this article

Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy

Author

Listed:
  • Vipul Bhatia

    (Fred Hutchinson Cancer Center)

  • Nikhil V. Kamat

    (University of Washington)

  • Tiffany E. Pariva

    (Fred Hutchinson Cancer Center)

  • Li-Ting Wu

    (Fred Hutchinson Cancer Center)

  • Annabelle Tsao

    (Fred Hutchinson Cancer Center)

  • Koichi Sasaki

    (Imperial College London)

  • Huiyun Sun

    (Fred Hutchinson Cancer Center)

  • Gerardo Javier

    (Fred Hutchinson Cancer Center)

  • Sam Nutt

    (Fred Hutchinson Cancer Center)

  • Ilsa Coleman

    (Fred Hutchinson Cancer Center)

  • Lauren Hitchcock

    (Fred Hutchinson Cancer Center)

  • Ailin Zhang

    (Fred Hutchinson Cancer Center)

  • Dmytro Rudoy

    (Fred Hutchinson Cancer Center)

  • Roman Gulati

    (Fred Hutchinson Cancer Center)

  • Radhika A. Patel

    (Fred Hutchinson Cancer Center)

  • Martine P. Roudier

    (University of Washington)

  • Lawrence D. True

    (University of Washington)

  • Shivani Srivastava

    (Fred Hutchinson Cancer Center)

  • Colm M. Morrissey

    (University of Washington)

  • Michael C. Haffner

    (Fred Hutchinson Cancer Center
    University of Washington
    Fred Hutchinson Cancer Center)

  • Peter S. Nelson

    (Fred Hutchinson Cancer Center
    University of Washington
    Fred Hutchinson Cancer Center
    University of Washington)

  • Saul J. Priceman

    (City of Hope
    Beckman Research Institute of City of Hope)

  • Jun Ishihara

    (Imperial College London)

  • John K. Lee

    (Fred Hutchinson Cancer Center
    University of Washington
    University of Washington
    Fred Hutchinson Cancer Center)

Abstract

Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a cell surface antigen for therapeutic targeting in prostate cancer. Here, we report broad expression of STEAP1 relative to prostate-specific membrane antigen (PSMA) in lethal metastatic prostate cancers and the development of a STEAP1-directed chimeric antigen receptor (CAR) T cell therapy. STEAP1 CAR T cells demonstrate reactivity in low antigen density, antitumor activity across metastatic prostate cancer models, and safety in a human STEAP1 knock-in mouse model. STEAP1 antigen escape is a recurrent mechanism of treatment resistance and is associated with diminished tumor antigen processing and presentation. The application of tumor-localized interleukin-12 (IL-12) therapy in the form of a collagen binding domain (CBD)-IL-12 fusion protein combined with STEAP1 CAR T cell therapy enhances antitumor efficacy by remodeling the immunologically cold tumor microenvironment of prostate cancer and combating STEAP1 antigen escape through the engagement of host immunity and epitope spreading.

Suggested Citation

  • Vipul Bhatia & Nikhil V. Kamat & Tiffany E. Pariva & Li-Ting Wu & Annabelle Tsao & Koichi Sasaki & Huiyun Sun & Gerardo Javier & Sam Nutt & Ilsa Coleman & Lauren Hitchcock & Ailin Zhang & Dmytro Rudoy, 2023. "Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37874-2
    DOI: 10.1038/s41467-023-37874-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-37874-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-37874-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Vincenzo Bronte & Sven Brandau & Shu-Hsia Chen & Mario P. Colombo & Alan B. Frey & Tim F. Greten & Susanna Mandruzzato & Peter J. Murray & Augusto Ochoa & Suzanne Ostrand-Rosenberg & Paulo C. Rodrigue, 2016. "Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards," Nature Communications, Nature, vol. 7(1), pages 1-10, November.
    2. Yao Wang & Chuan Tong & Hanren Dai & Zhiqiang Wu & Xiao Han & Yelei Guo & Deyun Chen & Jianshu Wei & Dongdong Ti & Zongzhi Liu & Qian Mei & Xiang Li & Liang Dong & Jing Nie & Yajing Zhang & Weidong Ha, 2021. "Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bihui Cao & Manting Liu & Lu Wang & Kangshun Zhu & Mingyue Cai & Xiaopei Chen & Yunfei Feng & Shuo Yang & Shengyu Fu & Cheng Zhi & Xiaodie Ye & Jian Zhang & Zhiru Zhang & Xin Yang & Ming Zhao & Qingde, 2022. "Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    2. Raquel S. Pereira & Rahul Kumar & Alessia Cais & Lara Paulini & Alisa Kahler & Jimena Bravo & Valentina R. Minciacchi & Theresa Krack & Eric Kowarz & Costanza Zanetti & Parimala Sonika Godavarthy & Fa, 2023. "Distinct and targetable role of calcium-sensing receptor in leukaemia," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    3. Weili Ma & Maria Cecília Oliveira-Nunes & Ke Xu & Andrew Kossenkov & Benjamin C. Reiner & Richard C. Crist & James Hayden & Qing Chen, 2023. "Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    4. Maxine S. Y. Lam & Jose Antonio Reales-Calderon & Jin Rong Ow & Joey J. Y. Aw & Damien Tan & Ragavi Vijayakumar & Erica Ceccarello & Tommaso Tabaglio & Yan Ting Lim & Wang Loo Chien & Fritz Lai & Anth, 2023. "G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    5. Yanan Tang & Turun Song & Lu Gao & Saifu Yin & Ming Ma & Yun Tan & Lijuan Wu & Yang Yang & Yanqun Wang & Tao Lin & Feng Li, 2022. "A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    6. Jing Wang & Ramon Ocadiz-Ruiz & Matthew S. Hall & Grace G. Bushnell & Sophia M. Orbach & Joseph T. Decker & Ravi M. Raghani & Yining Zhang & Aaron H. Morris & Jacqueline S. Jeruss & Lonnie D. Shea, 2023. "A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    7. J. K. Wiencke & Annette M. Molinaro & Gayathri Warrier & Terri Rice & Jennifer Clarke & Jennie W. Taylor & Margaret Wrensch & Helen Hansen & Lucie McCoy & Emily Tang & Stan J. Tamaki & Courtney M. Tam, 2022. "DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    8. Qiming Zhou & Yao Peng & Fenfen Ji & Huarong Chen & Wei Kang & Lam-Shing Chan & Hongyan Gou & Yufeng Lin & Pingmei Huang & Danyu Chen & Qinyao Wei & Hao Su & Cong Liang & Xiang Zhang & Jun Yu & Chi Ch, 2023. "Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    9. Saeed Daneshmandi & Jee Eun Choi & Qi Yan & Cameron R. MacDonald & Manu Pandey & Mounika Goruganthu & Nathan Roberts & Prashant K. Singh & Richard M. Higashi & Andrew N. Lane & Teresa W-M. Fan & Jianm, 2024. "Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    10. Ni Li & Qiuli Liu & Ying Han & Siyu Pei & Bisheng Cheng & Junyu Xu & Xiang Miao & Qiang Pan & Hanling Wang & Jiacheng Guo & Xuege Wang & Guoying Zhang & Yannan Lian & Wei Zhang & Yi Zang & Minjia Tan , 2022. "ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    11. Vincenzo Salemme & Mauro Vedelago & Alessandro Sarcinella & Federico Moietta & Alessio Piccolantonio & Enrico Moiso & Giorgia Centonze & Marta Manco & Andrea Guala & Alessia Lamolinara & Costanza Ange, 2023. "p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    12. Silvia Tiberti & Carlotta Catozzi & Ottavio Croci & Mattia Ballerini & Danilo Cagnina & Chiara Soriani & Caterina Scirgolea & Zheng Gong & Jiatai He & Angeli D. Macandog & Amir Nabinejad & Carina B. N, 2022. "GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome," Nature Communications, Nature, vol. 13(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37874-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.